These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34907234)
1. Alginate-amphotericin B nanocomplexes covered by nanocrystals from bacterial cellulose: physico-chemical characterization and in vitro toxicity. Soeiro VS; Silva-Carvalho R; Martins D; Parpot P; Grotto D; Chaud MV; da Gama FMP; Jozala AF Sci Rep; 2021 Dec; 11(1):23944. PubMed ID: 34907234 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of anti-fungal activities of sodium alginate-amphotericin B conjugates. Ravichandran V; Jayakrishnan A Int J Biol Macromol; 2018 Mar; 108():1101-1109. PubMed ID: 29126939 [TBL] [Abstract][Full Text] [Related]
3. Development of dextrin-amphotericin B formulations for the treatment of Leishmaniasis. Silva-Carvalho R; Fidalgo J; Melo KR; Queiroz MF; Leal S; Rocha HA; Cruz T; Parpot P; Tomás AM; Gama M Int J Biol Macromol; 2020 Jun; 153():276-288. PubMed ID: 32145228 [TBL] [Abstract][Full Text] [Related]
5. Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents. Ravichandran V; Kesavan V; Cojean S; Loiseau PM; Jayakrishnan A Curr Drug Deliv; 2018; 15(7):1028-1037. PubMed ID: 29732967 [TBL] [Abstract][Full Text] [Related]
6. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection. Kaur K; Kumar P; Kush P Biomed Pharmacother; 2020 Aug; 128():110297. PubMed ID: 32480227 [TBL] [Abstract][Full Text] [Related]
7. Amphotericin B-albumin conjugates: Synthesis, toxicity and anti-fungal activity. Gurudevan S; Francis AP; Jayakrishnan A Eur J Pharm Sci; 2018 Mar; 115():167-174. PubMed ID: 29325755 [TBL] [Abstract][Full Text] [Related]
8. Self-assembling cashew gum-graft-polylactide copolymer nanoparticles as a potential amphotericin B delivery matrix. Richter AR; Carneiro MJ; de Sousa NA; Pinto VPT; Freire RS; de Sousa JS; Mendes JFS; Fontenelle ROS; Feitosa JPA; Paula HCB; Goycoolea FM; de Paula RCM Int J Biol Macromol; 2020 Jun; 152():492-502. PubMed ID: 32097738 [TBL] [Abstract][Full Text] [Related]
9. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles. Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532 [TBL] [Abstract][Full Text] [Related]
12. Amphotericin B formulations: a comparative review of efficacy and toxicity. Hamill RJ Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001 [TBL] [Abstract][Full Text] [Related]
13. Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B. Thanki K; Prajapati R; Sangamwar AT; Jain S Int J Pharm; 2018 Jun; 544(1):1-13. PubMed ID: 29635057 [TBL] [Abstract][Full Text] [Related]
14. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B. Alvarez C; Shin DH; Kwon GS Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671 [TBL] [Abstract][Full Text] [Related]
15. Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations. Jansook P; Pichayakorn W; Ritthidej GC Drug Dev Ind Pharm; 2018 Oct; 44(10):1693-1700. PubMed ID: 29936874 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation. Gangadhar KN; Adhikari K; Srichana T Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597 [TBL] [Abstract][Full Text] [Related]
17. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B. Falamarzian A; Lavasanifar A Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292 [TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion. Rochelle do Vale Morais A; Silva AL; Cojean S; Balaraman K; Bories C; Pomel S; Barratt G; do Egito EST; Loiseau PM Exp Parasitol; 2018 Sep; 192():85-92. PubMed ID: 30075233 [TBL] [Abstract][Full Text] [Related]
19. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo. Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279 [TBL] [Abstract][Full Text] [Related]
20. Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin B. Diezi TA; Kwon G Pharm Res; 2012 Jul; 29(7):1737-44. PubMed ID: 22130733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]